Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncogenic B-Raf mutations: crystal clear at last.

Amardeep S Dhillon1, Walter Kolch

  • 1The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, United Kingdom.

Cancer Cell
|April 20, 2004
PubMed
Summary

The Raf/MEK/ERK pathway regulates cell growth. New crystal structures of B-Raf kinase reveal how mutations in this pathway drive cancer, offering insights into cell transformation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strengthening translational medical research in Ireland: an interdisciplinary framework for clinician-scientist collaboration.

Irish journal of medical science·2026
Same author

Digital Twin models to address long-term treatment toxicities in children and young adults with cancer.

NPJ digital medicine·2026
Same author

Unique B- and plasma cell signature differentiates hidradenitis suppurativa from psoriasis and atopic dermatitis.

Frontiers in immunology·2026
Same author

Dual RAF inhibition outperforms RAF-MEK combinations for suppressing ERK signaling in KRAS mutant cells.

NPJ systems biology and applications·2026
Same author

Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced <i>KRAS</i>-Mutated Metastatic Pancreatic Cancer.

Journal of immunotherapy and precision oncology·2026
Same author

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Molecular oncology·2026

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • The Raf/MEK/ERK pathway is crucial for cellular functions like growth and differentiation.
  • Aberrant signaling in this pathway contributes to cancer development, often driven by oncogenes such as Ras.
  • Recent identification of B-RAF gene mutations in human tumors highlights the need to understand Raf kinase regulation.

Discussion:

  • Wan et al. present the crystal structure of the B-Raf kinase domain.
  • This structural information provides critical insights into the regulation of B-Raf kinase activity.
  • Understanding B-Raf regulation is key to deciphering its role in oncogenic transformation.

Key Insights:

  • The crystal structure elucidates the molecular mechanisms underlying B-Raf kinase function.
  • Structural data can explain how specific B-RAF mutations lead to constitutive activation and cancer.
  • This provides a foundation for targeted therapeutic strategies.

Outlook:

  • Further structural studies of B-Raf mutants could reveal drug resistance mechanisms.
  • The findings pave the way for designing novel inhibitors targeting oncogenic B-Raf.
  • Understanding Raf pathway dysregulation is essential for advancing cancer therapy.

Related Experiment Videos